Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers
- PMID: 28791818
- DOI: 10.17219/acem/62214
Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers
Abstract
Background: Pre-eclampsia is a systemic disease connected with high maternal and fetal morbidity and mortality. Despite significant progress achieved in perinatal medicine, pre-eclampsia is still one of the most significant current problems in obstetrics.
Objectives: The aim of the study was to establish diagnostic algorithms for early and late pre-eclampsia (PE) and intrauterine growth restriction (IUGR).
Material and methods: A total of 320 pregnant women between 11 + 0 and 13 + 6 weeks of gestation were recruited for a case-control study. The study group consisted of 22 patients with early PE, 29 patients with late PE and 269 unaffected controls. The following parameters were recorded: maternal history, mean arterial pressure (MAP), mean uterine artery pulsatility index (UtA-PI), and the concentrations of placental growth factor (PlGF), pregnancy-associated plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (free β-hCG).
Results: A multivariable stepwise logistic regression analysis indicated that the best screening model for the prediction of early PE is based on a combined analysis of maternal risk factors, UtA-PI and PlGF levels (sensitivity: 91%; specificity: 84%). The best screening model for the prediction of late PE is based on a combined analysis of maternal risk factors, UtA-PI and MAP (sensitivity: 85%; specificity: 83%). The most effective screening model for the prediction of IUGR is based on a combined analysis of maternal risk factors, UtA-PI and PlGF concentrations (sensitivity: 91%; specificity: 83%).
Conclusions: The integrated model of screening established in this study can be a valuable method to identify patients at increased risk of developing pre-eclampsia and related complications. The ability to predict the occurrence of pre-eclampsia in early pregnancy would enable maternal and fetal morbidity to be reduced through the introduction of strict obstetric surveillance as well as planned delivery in a reference center.
Keywords: diagnostic algorithms; placental growth factor; pre-eclampsia.
Similar articles
-
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.Ultrasound Obstet Gynecol. 2020 Sep;56(3):400-407. doi: 10.1002/uog.22093. Epub 2020 Aug 5. Ultrasound Obstet Gynecol. 2020. PMID: 32441401
-
Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.BMC Pregnancy Childbirth. 2018 Jul 3;18(1):279. doi: 10.1186/s12884-018-1908-9. BMC Pregnancy Childbirth. 2018. PMID: 29970026 Free PMC article. Clinical Trial.
-
Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.Ultrasound Obstet Gynecol. 2015 Oct;46(4):446-51. doi: 10.1002/uog.14863. Epub 2015 Aug 6. Ultrasound Obstet Gynecol. 2015. PMID: 25826154
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
-
A placenta clinic approach to the diagnosis and management of fetal growth restriction.Am J Obstet Gynecol. 2018 Feb;218(2S):S803-S817. doi: 10.1016/j.ajog.2017.11.575. Epub 2017 Dec 15. Am J Obstet Gynecol. 2018. PMID: 29254754 Review.
Cited by
-
Personalized Model to Predict Small for Gestational Age at Delivery Using Fetal Biometrics, Maternal Characteristics, and Pregnancy Biomarkers: A Retrospective Cohort Study of Births Assisted at a Spanish Hospital.J Pers Med. 2022 May 8;12(5):762. doi: 10.3390/jpm12050762. J Pers Med. 2022. PMID: 35629184 Free PMC article.
-
Can Fetal Growth Velocity and First Trimester Maternal Biomarkers Improve the Prediction of Small-for-Gestational Age and Adverse Neonatal Outcome?Fetal Diagn Ther. 2019;46(4):274-284. doi: 10.1159/000499580. Epub 2019 May 8. Fetal Diagn Ther. 2019. PMID: 31067557 Free PMC article.
-
Unravelling the potential of angiogenic factors for the early prediction of preeclampsia.Hypertens Res. 2021 Jul;44(7):756-769. doi: 10.1038/s41440-021-00647-9. Epub 2021 Apr 1. Hypertens Res. 2021. PMID: 33795844 Review.
-
Assessing the Role of Uric Acid as a Predictor of Preeclampsia.Front Physiol. 2022 Jan 13;12:785219. doi: 10.3389/fphys.2021.785219. eCollection 2021. Front Physiol. 2022. PMID: 35095555 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous